Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The UFM1 Pathway Impacts HCMV US2-Mediated Degradation of HLA Class I. | Molecules | 2021 | 33430125 | PubTator, text mining | PubMed |
| Role of GTPases in Driving Mitoribosome Assembly. | Trends Cell Biol | 2021 | 33419649 | PubTator, text mining | PubMed |
| Generation of a Novel Mesothelin-Targeted Oncolytic Herpes Virus and Implemented Strategies for Manufacturing. | Int J Mol Sci | 2021 | 33418877 | PubTator, text mining | PubMed |
| CONCOMITANT MUTATIONS IN INHERITED RETINAL DYSTROPHIES: Why the Reproductive and Therapeutic Counseling Should Be Addressed Cautiously. | Retina | 2021 | 33411470 | PubTator, text mining | PubMed |
| Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinoma. | Cancer Immunol Immunother | 2021 | 33386920 | PubTator, text mining | PubMed |
| Genetic approaches toward understanding the individual variation in cardiac structure, function and responses to exercise training. | Korean J Physiol Pharmacol | 2021 | 33361533 | PubTator, text mining | PubMed |
| Generation of three induced pluripotent stem cell lines from a patient with Usher syndrome caused by biallelic c.949C > A and c.1256G > T mutations in the USH2A gene. | Stem Cell Res | 2021 | 33360097 | PubTator, text mining | PubMed |
| Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development Therapeutics. | Mol Ther | 2021 | 33359792 | PubTator, text mining | PubMed |
| RAD51AP1 promotes progression of ovarian cancer via TGF-β/Smad signalling pathway. | J Cell Mol Med | 2021 | 33314567 | PubTator, text mining | PubMed |
| The Diseased Mitoribosome. | FEBS Lett | 2021 | 33314036 | PubTator, text mining | PubMed |
| RNA therapeutics for retinal diseases. | Expert Opin Biol Ther | 2021 | 33307874 | PubTator, text mining | PubMed |
| USH2A is a Meissner's corpuscle protein necessary for normal vibration sensing in mice and humans. | Nat Neurosci | 2021 | 33288907 | PubTator, text mining | PubMed |
| A highly heterogeneous mutational pattern in POEMS syndrome. | Leukemia | 2021 | 33262528 | PubTator, text mining | PubMed |
| Detection and validation of novel mutations in MERTK in a simplex case of retinal degeneration using WGS and hiPSC-RPEs model. | Hum Mutat | 2021 | 33252167 | PubTator, text mining | PubMed |
| Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma. | Transl Oncol | 2021 | 33246289 | PubTator, text mining | PubMed |
| Translational and interdisciplinary insights into presbyacusis: A multidimensional disease. | Hear Res | 2021 | 33189490 | PubTator, text mining | PubMed |
| Promises and pitfalls of evaluating photoreceptor-based retinal disease with adaptive optics scanning light ophthalmoscopy (AOSLO). | Prog Retin Eye Res | 2021 | 33161127 | PubTator, text mining | PubMed |
| Patient derived stem cells for discovery and validation of novel pathogenic variants in inherited retinal disease. | Prog Retin Eye Res | 2021 | 33130253 | PubTator, text mining | PubMed |
| Correlation between Genotype and Phenotype in 69 Chinese Patients with USH2A Mutations: A comparative study of the patients with Usher Syndrome and Nonsyndromic Retinitis Pigmentosa. | Acta Ophthalmol | 2021 | 33124170 | PubTator, text mining | PubMed |
| Genetic Testing Leading to Early Identification of Childhood Ocular Manifestations of Usher Syndrome. | Laryngoscope | 2021 | 33111992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=56